Medicare Spending on Drugs With Accelerated Approval
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/m21-4442
Abstract: BACKGROUND The U.S. Food and Drug Administration provides accelerated approval to drugs on the basis of surrogate end points deemed to be "reasonably likely" to predict clinical benefit. To receive full approval, drugs must complete… read more here.
Keywords: full approval; approval; spending drugs; medicare spending ... See more keywords